Key result
Adenosine effectively terminates PSVT, offering a promising alternative due to its short half-life and safety.
Why the study?
Further controlled prospective studies are needed before adenosine can become the drug of choice in managing paroxysmal supraventricular tachycardia in children.
Does adenosine improve the termination of paroxysmal supraventricular tachycardia in children?
Does adenosine improve the termination of paroxysmal supraventricular tachycardia in children?
Adenosine is a highly effective and promising alternative for terminating paroxysmal supraventricular tachycardia, though further prospective studies are needed to establish it as the drug of choice in children.
Answers are grounded in this paper and cite their sources.
Adenosine may serve as a safe alternative for pediatric PSVT termination; leaves open first-line status pending prospective trials.
In summary, adenosine is highly effective in terminating paroxysmal supraventricular tachycardia, and its very short half-life and benign side effects make it a promising alternative to other modes of therapy presently used. Further controlled prospective studies are needed before adenosine can become the drug of choice in the management of paroxysmal supraventricular tachycardia in children.
No takes yet. Share an insight, caveat, or question.
ROS et al. (1991) studied this question. Adenosine is highly effective in terminating paroxysmal supraventricular tachycardia, offering a promising alternative therapy due to its short half-life and benign side effects.
Synapse has enriched 10 related papers. Consider them for comparative context: